Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.

  • Álvarez, Eva G
  • Demeulemeester, Jonas
  • Otero, Paula
  • Jolly, Clemency
  • García-Souto, Daniel
  • Pequeño-Valtierra, Ana
  • Zamora, Jorge
  • Tojo, Marta
  • Temes, Javier
  • Baez-Ortega, Adrian
  • Rodriguez-Martin, Bernardo
  • Oitaben, Ana
  • Bruzos, Alicia L
  • Martínez-Fernández, Mónica
  • Haase, Kerstin
  • Zumalave, Sonia
  • Abal, Rosanna
  • Rodríguez-Castro, Jorge
  • Rodriguez-Casanova, Aitor
  • Diaz-Lagares, Angel
  • Li, Yilong
  • Raine, Keiran M
  • Butler, Adam P
  • Otero, Iago
  • Ono, Atsushi
  • Aikata, Hiroshi
  • Chayama, Kazuaki
  • Ueno, Masaki
  • Hayami, Shinya
  • Yamaue, Hiroki
  • Maejima, Kazuhiro
  • Blanco, Miguel G
  • Forns, Xavier
  • Rivas, Carmen
  • Ruiz-Bañobre, Juan
  • Pérez-Del-Pulgar, Sofía
  • Torres-Ruiz, Raul
  • Rodriguez Perales, Sandra
  • Garaigorta, Urtzi
  • Tubio, Jose M C
  • Campbell, Peter J
  • Nakagawa, Hidewaki
  • Van Loo, Peter
Most cancers are characterized by the somatic acquisition of genomic rearrangements during tumour evolution that eventually drive the oncogenesis. Here, using multiplatform sequencing technologies, we identify and characterize a remarkable mutational mechanism in human hepatocellular carcinoma caused by Hepatitis B virus, by which DNA molecules from the virus are inserted into the tumour genome causing dramatic changes in its configuration, including non-homologous chromosomal fusions, dicentric chromosomes and megabase-size telomeric deletions. This aberrant mutational mechanism, present in at least 8% of all HCC tumours, can provide the driver rearrangements that a cancer clone requires to survive and grow, including loss of relevant tumour suppressor genes. Most of these events are clonal and occur early during liver cancer evolution. Real-time timing estimation reveals some HBV-mediated rearrangements occur as early as two decades before cancer diagnosis. Overall, these data underscore the importance of characterising liver cancer genomes for patterns of HBV integration.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures

  • Collord, Grace
  • Tarpey, Patrick
  • Kurbatova, Natalja
  • Martincorena, Inigo
  • Morán, Sebastián
  • Castro, Manuel
  • Nagy, Tibor
  • Bignell, Graham
  • Maura, Francesco
  • Young, Matthew D.
  • Berna, Jorge
  • Castro Tubío, José Manuel
  • McMurran, Chris E.
  • Young, Adam M.H.
  • Sanders, Mathijs
  • Noorani, Imran
  • Price, Stephen J.
  • Watts, Colin
  • Leipnitz, Elke
  • Kirsch, Matthias
  • Schackert, Gabriele
  • Pearson, Danita
  • Devadass, Abel
  • Ram, Zvi
  • Collins, V. Peter
  • Allinson, Kieren
  • Jenkinson, Michael D.
  • Zakaria, Rasheed
  • Syed, Khaja
  • Hanemann, C. Oliver
  • Dunn, Jemma
  • McDermott, Michael W.
  • Kirollos, Ramez W.
  • Vassiliou, George S.
  • Esteller, Manel
  • Behjati, Sam
  • Brazma, Alvis
  • Santarius, Thomas
  • McDermott, Ultan
Anaplastic meningioma is a rare and aggressive brain tumor characterised by intractable recurrences and dismal outcomes. Here, we present an integrated analysis of the whole genome, transcriptome and methylation profiles of primary and recurrent anaplastic meningioma. A key finding was the delineation of distinct molecular subgroups that were associated with diametrically opposed survival outcomes. Relative to lower grade meningiomas, anaplastic tumors harbored frequent driver mutations in SWI/SNF complex genes, which were confined to the poor prognosis subgroup. Aggressive disease was further characterised by transcriptional evidence of increased PRC2 activity, stemness and epithelial-to-mesenchymal transition. Our analyses discern biologically distinct variants of anaplastic meningioma with prognostic and therapeutic significance